Cencora Operating Margin 2012-2026 | COR
Current and historical operating margin for Cencora (COR) over the last 10 years. The current operating profit margin for Cencora as of June 30, 2026 is 1.01%.
| Cencora Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2026-06-30 | $332.77B | $3.04B | 0.91% |
| 2026-03-31 | $328.68B | $2.79B | 0.85% |
| 2025-12-31 | $325.78B | $2.68B | 0.82% |
| 2025-09-30 | $321.33B | $2.63B | 0.82% |
| 2025-06-30 | $316.66B | $2.74B | 0.86% |
| 2025-03-31 | $310.23B | $2.54B | 0.82% |
| 2024-12-31 | $303.19B | $2.06B | 0.68% |
| 2024-09-30 | $293.96B | $2.18B | 0.74% |
| 2024-06-30 | $283.83B | $2.53B | 0.89% |
| 2024-03-31 | $276.54B | $2.52B | 0.91% |
| 2023-12-31 | $271.58B | $2.53B | 0.93% |
| 2023-09-30 | $262.17B | $2.34B | 0.89% |
| 2023-06-30 | $254.43B | $2.32B | 0.91% |
| 2023-03-31 | $247.54B | $2.14B | 0.86% |
| 2022-12-31 | $241.81B | $2.36B | 0.97% |
| 2022-09-30 | $238.59B | $2.37B | 0.99% |
| 2022-06-30 | $236.33B | $2.47B | 1.05% |
| 2022-03-31 | $229.67B | $2.61B | 1.14% |
| 2021-12-31 | $221.10B | $2.45B | 1.11% |
| 2021-09-30 | $213.99B | $2.35B | 1.10% |
| 2021-06-30 | $204.32B | $-4.32B | -2.11% |
| 2021-03-31 | $196.28B | $-4.54B | -2.31% |
| 2020-12-31 | $194.55B | $-4.85B | -2.49% |
| 2020-09-30 | $189.90B | $-5.14B | -2.70% |
| 2020-06-30 | $186.29B | $1.16B | 0.62% |
| 2020-03-31 | $186.16B | $1.16B | 0.62% |
| 2019-12-31 | $182.06B | $0.90B | 0.49% |
| 2019-09-30 | $179.59B | $1.11B | 0.62% |
| 2019-06-30 | $177.25B | $1.09B | 0.61% |
| 2019-03-31 | $175.15B | $1.07B | 0.61% |
| 2018-12-31 | $172.87B | $1.50B | 0.87% |
| 2018-09-30 | $167.94B | $1.44B | 0.86% |
| 2018-06-30 | $163.76B | $1.15B | 0.70% |
| 2018-03-31 | $159.33B | $0.94B | 0.59% |
| 2017-12-31 | $155.44B | $1.08B | 0.69% |
| 2017-09-30 | $153.14B | $1.06B | 0.69% |
| 2017-06-30 | $151.58B | $1.42B | 0.94% |
| 2017-03-31 | $149.76B | $1.78B | 1.19% |
| 2016-12-31 | $148.31B | $2.10B | 1.42% |
| 2016-09-30 | $146.85B | $1.53B | 1.04% |
| 2016-06-30 | $144.76B | $1.84B | 1.27% |
| 2016-03-31 | $142.11B | $1.65B | 1.16% |
| 2015-12-31 | $139.08B | $0.33B | 0.24% |
| 2015-09-30 | $135.96B | $0.42B | 0.31% |
| 2015-06-30 | $132.08B | $0.09B | 0.07% |
| 2015-03-31 | $128.20B | $-0.13B | -0.10% |
| 2014-12-31 | $123.98B | $0.53B | 0.43% |
| 2014-09-30 | $119.57B | $0.78B | 0.65% |
| 2014-06-30 | $112.45B | $0.69B | 0.61% |
| 2014-03-31 | $104.01B | $0.71B | 0.68% |
| 2013-12-31 | $96.08B | $0.76B | 0.79% |
| 2013-09-30 | $87.96B | $0.90B | 1.02% |
| 2013-06-30 | $82.23B | $1.11B | 1.34% |
| 2013-03-31 | $79.65B | $1.29B | 1.62% |
| 2012-12-31 | $78.83B | $1.32B | 1.68% |
| 2012-09-30 | $78.08B | $1.30B | 1.67% |
| 2012-06-30 | $78.23B | $1.21B | 1.55% |
| 2012-03-31 | $79.07B | $1.21B | 1.52% |
| 2011-12-31 | $79.12B | $1.19B | 1.51% |
| 2011-09-30 | $78.70B | $1.19B | 1.51% |
| 2011-06-30 | $79.35B | $1.20B | 1.51% |
| 2011-03-31 | $78.79B | $1.16B | 1.47% |
| 2010-12-31 | $78.33B | $1.11B | 1.41% |
| 2010-09-30 | $77.78B | $1.09B | 1.40% |
| 2010-06-30 | $76.96B | $1.08B | 1.40% |
| 2010-03-31 | $75.75B | $1.01B | 1.33% |
| 2009-12-31 | $73.76B | $0.95B | 1.29% |
| 2009-09-30 | $71.76B | $0.88B | 1.23% |
| 2009-06-30 | $70.20B | $0.86B | 1.23% |
| 2009-03-31 | $69.81B | $0.85B | 1.21% |
| 2008-12-31 | $70.25B | $0.83B | 1.19% |
| 2008-09-30 | $70.19B | $0.83B | 1.18% |
| 2008-06-30 | $69.12B | $0.78B | 1.13% |
| 2008-03-31 | $67.47B | $0.79B | 1.17% |
| 2007-12-31 | $66.23B | $0.77B | 1.17% |
| 2007-09-30 | $65.67B | $0.79B | 1.20% |
| 2007-06-30 | $64.83B | $0.77B | 1.19% |
| 2007-03-31 | $64.18B | $0.76B | 1.18% |
| 2006-12-31 | $62.88B | $0.74B | 1.17% |
| 2006-09-30 | $60.81B | $0.69B | 1.14% |
| 2006-06-30 | $59.48B | $0.71B | 1.19% |
| 2006-03-31 | $57.62B | $0.69B | 1.20% |
| 2005-12-31 | $55.59B | $0.67B | 1.21% |
| 2005-09-30 | $54.58B | $0.64B | 1.17% |
| 2005-06-30 | $54.03B | $0.66B | 1.22% |
| 2005-03-31 | $53.25B | $0.74B | 1.40% |
| 2004-12-31 | $53.42B | $0.82B | 1.54% |
| 2004-09-30 | $53.12B | $0.90B | 1.69% |
| 2004-06-30 | $52.32B | $0.96B | 1.83% |
| 2004-03-31 | $51.68B | $0.93B | 1.80% |
| 2003-12-31 | $50.49B | $0.91B | 1.80% |
| 2003-09-30 | $49.59B | $0.89B | 1.79% |
| 2003-06-30 | $48.62B | $0.85B | 1.74% |
| 2003-03-31 | $47.82B | $0.80B | 1.68% |
| 2002-12-31 | $46.60B | $0.76B | 1.62% |
| 2002-09-30 | $45.24B | $0.72B | 1.59% |
| 2002-06-30 | $39.52B | $0.63B | 1.58% |
| 2002-03-31 | $31.42B | $0.50B | 1.60% |
| 2001-12-31 | $23.95B | $0.38B | 1.57% |
| 2001-09-30 | $16.19B | $0.28B | 1.72% |
| 2001-06-30 | $13.34B | $0.23B | 1.75% |
| 2001-03-31 | $12.75B | $0.22B | 1.74% |
| 2000-12-31 | $12.11B | $0.21B | 1.73% |
| 2000-09-30 | $11.65B | $0.20B | 1.73% |
| 2000-06-30 | $11.19B | $-0.42B | -3.76% |
| 2000-03-31 | $10.52B | $-0.43B | -4.09% |
| 1999-12-31 | $9.86B | $-0.44B | -4.45% |
| 1999-09-30 | $9.19B | $-0.45B | -4.88% |
| 1999-06-30 | $8.86B | $0.28B | 3.18% |
| 1999-03-31 | $8.69B | $0.28B | 3.22% |
| 1998-12-31 | $8.71B | $0.28B | 3.18% |
| 1998-09-30 | $8.79B | $0.28B | 3.14% |
| 1998-06-30 | $8.76B | $0.15B | 1.70% |
| 1998-03-31 | $8.73B | $0.13B | 1.52% |
| 1997-12-31 | $8.32B | $0.13B | 1.53% |
| 1997-09-30 | $7.82B | $0.12B | 1.54% |
| 1997-06-30 | $7.08B | $0.10B | 1.44% |
| 1997-03-31 | $6.44B | $0.11B | 1.68% |
| 1996-12-31 | $6.02B | $0.10B | 1.70% |
| 1996-09-30 | $5.55B | $0.10B | 1.75% |
| 1996-06-30 | $5.27B | $0.19B | 3.61% |
| 1996-03-31 | $5.04B | $0.19B | 3.71% |
| 1995-12-31 | $3.68B | $-1.02B | -27.76% |
| 1995-09-30 | $3.55B | $-1.02B | -28.80% |
| 1995-06-30 | $3.43B | $-0.05B | -1.49% |
| 1995-03-31 | $3.32B | $1.00B | 30.24% |
| 1994-12-31 | $4.39B | $3.25B | 74.12% |
| 1994-09-30 | $4.28B | $4.28B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.254B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |